PL2138848T3 - Sposób diagnozowania i/lub prognozowania raka pęcherza moczowego - Google Patents

Sposób diagnozowania i/lub prognozowania raka pęcherza moczowego

Info

Publication number
PL2138848T3
PL2138848T3 PL07788578T PL07788578T PL2138848T3 PL 2138848 T3 PL2138848 T3 PL 2138848T3 PL 07788578 T PL07788578 T PL 07788578T PL 07788578 T PL07788578 T PL 07788578T PL 2138848 T3 PL2138848 T3 PL 2138848T3
Authority
PL
Poland
Prior art keywords
prognosis
bladder
diagnosis
cancer
quantification
Prior art date
Application number
PL07788578T
Other languages
English (en)
Inventor
Asensio Antonio Alcaraz
Brichs Lourdes Mengual
Albareda Moises Burset
Caparros Maria Jose Ribal
Criach Elisabet Ars
Original Assignee
Fina Biotech Slu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fina Biotech Slu filed Critical Fina Biotech Slu
Publication of PL2138848T3 publication Critical patent/PL2138848T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07788578T 2007-03-20 2007-06-05 Sposób diagnozowania i/lub prognozowania raka pęcherza moczowego PL2138848T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200700727A ES2304306B1 (es) 2007-03-20 2007-03-20 Metodo de diagnostico y/o pronostico de cancer vesical.
EP07788578A EP2138848B1 (en) 2007-03-20 2007-06-05 Method for the diagnosis and/or prognosis of cancer of the bladder
PCT/ES2007/000330 WO2008113870A1 (es) 2007-03-20 2007-06-05 Método de diagnóstico y/o pronóstico de cancer vesical

Publications (1)

Publication Number Publication Date
PL2138848T3 true PL2138848T3 (pl) 2011-11-30

Family

ID=39758544

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07788578T PL2138848T3 (pl) 2007-03-20 2007-06-05 Sposób diagnozowania i/lub prognozowania raka pęcherza moczowego

Country Status (13)

Country Link
US (1) US9097715B2 (pl)
EP (1) EP2138848B1 (pl)
JP (1) JP5314667B2 (pl)
CN (1) CN101730848A (pl)
AT (1) ATE487140T1 (pl)
CA (1) CA2693847C (pl)
DE (1) DE602007010360D1 (pl)
DK (1) DK2138848T3 (pl)
ES (2) ES2304306B1 (pl)
PL (1) PL2138848T3 (pl)
PT (1) PT2138848E (pl)
SI (1) SI2138848T1 (pl)
WO (1) WO2008113870A1 (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010078411A1 (en) * 2008-12-30 2010-07-08 Children's Medical Center Corporation Method of predicting acute appendicitis
EP3812469A1 (en) * 2010-07-07 2021-04-28 Myriad Genetics, Inc. Gene signatures for cancer prognosis
JP5883443B2 (ja) * 2010-07-22 2016-03-15 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規の抗原結合タンパク質
US20130296175A1 (en) * 2011-01-13 2013-11-07 Illumina Inc. Genetic Variants as Markers for Use in Urinary Bladder Cancer Risk Assessment, Diagnosis, Prognosis and Treatment
CA2840472A1 (en) * 2011-06-22 2012-12-27 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of bladder cancer
US9249467B2 (en) 2011-09-16 2016-02-02 Steven Goodison Bladder cancer detection composition, kit and associated methods
CN103827313B (zh) * 2011-09-20 2016-06-29 深圳华大基因股份有限公司 膀胱移行细胞癌易感性的相关基因及其预测方法和系统
AU2012340393B2 (en) * 2011-11-15 2018-06-14 Oncocyte Corporation Methods and compositions for the treatment and diagnosis of bladder cancer
ES2601460T3 (es) 2011-12-30 2017-02-15 Abbott Molecular Inc. Materiales y métodos para el diagnóstico del cáncer de vejiga y el control de la recurrencia del mismo
EP2839028B1 (en) 2012-04-20 2016-12-28 Cepheid Methods of detecting bladder cancer
EP2762574A1 (en) 2013-01-31 2014-08-06 Fina Biotech, S.L. Non-invasive diagnostic method for diagnosing bladder cancer
JP2016513961A (ja) 2013-03-06 2016-05-19 セファイド 膀胱癌を検出する方法
WO2015013233A2 (en) * 2013-07-23 2015-01-29 Oncocyte Corp Methods and compositions for the treatment and diagnosis of bladder cancer
US10304188B1 (en) 2015-03-27 2019-05-28 Caleb J. Kumar Apparatus and method for automated cell analysis
US11391744B2 (en) 2015-06-08 2022-07-19 Arquer Diagnostic Limited Methods and kits
ES2806498T3 (es) 2015-06-08 2021-02-17 Arquer Diagnostics Ltd Métodos para el análisis de una muestra de orina
EP3332027A1 (en) * 2015-08-06 2018-06-13 Stichting Katholieke Universiteit Method for the prediction of progression of bladder cancer
CN105368959B (zh) * 2015-12-15 2019-01-04 甘肃中天羊业股份有限公司 Anxa10基因作为绵羊免疫性状的分子标记及其应用
WO2018219342A1 (zh) * 2017-06-01 2018-12-06 立森印迹诊断技术有限公司 一种印记基因分级模型和诊断方法及其应用
WO2018218737A1 (zh) * 2017-06-01 2018-12-06 立森印迹诊断技术（无锡）有限公司 一种印记基因在膀胱肿瘤中的分级模型及其组成的系统
CN108414756A (zh) * 2017-10-25 2018-08-17 深圳市罗湖区人民医院 一种同时检测尿液中四个膀胱癌标志物的蛋白芯片的制备方法
CN108414755A (zh) * 2017-10-25 2018-08-17 深圳市罗湖区人民医院 一种同时检测尿液中四个膀胱癌标志物的蛋白芯片
CN108866194B (zh) 2018-08-16 2021-03-26 杭州可帮基因科技有限公司 一组用于膀胱癌检测的基因及其应用
CN109797221A (zh) * 2019-03-13 2019-05-24 上海市第十人民医院 一种用于对肌层浸润性膀胱癌进行分子分型和/或预后预测的生物标记物组合及其应用
CN112378708B (zh) * 2020-11-04 2024-03-26 中国人民解放军陆军装甲兵学院 一种基于Bayes方法小样本条件下装备评估装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1318504B1 (it) * 2000-05-08 2003-08-27 Talent Srl Metodo e apparecchiatura per la diagnosi precoce di tumori vescicalisu campioni di urina.

Also Published As

Publication number Publication date
JP2010521981A (ja) 2010-07-01
ATE487140T1 (de) 2010-11-15
EP2138848A1 (en) 2009-12-30
ES2304306B1 (es) 2009-07-07
DK2138848T3 (da) 2011-02-21
EP2138848B1 (en) 2010-11-03
ES2304306A1 (es) 2008-10-01
CA2693847A1 (en) 2008-09-25
WO2008113870A1 (es) 2008-09-25
CA2693847C (en) 2016-08-02
PT2138848E (pt) 2011-02-08
US20100086932A1 (en) 2010-04-08
CN101730848A (zh) 2010-06-09
ES2357784T3 (es) 2011-04-29
JP5314667B2 (ja) 2013-10-16
EP2138848A4 (en) 2010-03-31
SI2138848T1 (sl) 2011-04-29
DE602007010360D1 (de) 2010-12-16
US9097715B2 (en) 2015-08-04

Similar Documents

Publication Publication Date Title
PL2138848T3 (pl) Sposób diagnozowania i/lub prognozowania raka pęcherza moczowego
GB2483810B (en) Methods for correlating clonotypes with diseases in a population
WO2009069984A3 (en) Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
WO2008079269A3 (en) Novel methods for functional analysis of high-throughput experimental data and gene groups identified therfrom
NZ595356A (en) Methods of predicting cancer risk using gene expression in premalignant tissue
WO2007146668A3 (en) Use of imp3 as a prognostic marker for cancer
WO2008146309A3 (en) Genetic variants on chr 5pl2 and 10q26 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
EP2444505A3 (en) Urine markers for detection of bladder cancer
DK3059322T3 (da) Genekspressionsmarkører for brystcancerprognose
WO2005067391A3 (en) Diagnostic test for parkinson's disease
ATE524740T1 (de) Seprase als krebsmarker
UA93989C2 (ru) Способ прогнозирования otbeta ha лечение
WO2008031839A3 (en) Gene expression signature for the prognosis, diagnosis, and therapy of prostate cancer and uses thereof
EP2527466A3 (en) Genetic variants on CHR2 as markers for use in breast cancer risk assessment, diagnosis, prognosis and treatment
EP2522743A3 (en) Genetic variants contributing to risk of prostate cancer
WO2011056489A3 (en) Diagnostic methods for determining prognosis of non-small cell lung cancer
FI2398902T3 (fi) Menetelmiä ja koostumuksia syövän diagnoosia ja hoitoa varten
WO2010004590A3 (en) Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
WO2009057294A1 (ja) 肝臓癌関連遺伝子、及び肝臓癌リスクの判定方法
WO2007133551A3 (en) Method for testing drug sensitivity in solid tumors by quantifying mrna expression in thinly-sliced tumor tissue
WO2006089185A3 (en) Pharmacogenomic markers for prognosis of solid tumors
MX2013004747A (es) Marcadores de gen de sangre periferica para el diagnostico temprano de la enfermedad de parkinson.
AU2010202926B2 (en) Markers and methods relating to the assessment of Alzheimer's disease
WO2010051261A3 (en) A genetic marker for detection of human papillomavirus
WO2009065511A3 (en) Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders